AI for finance

Guiding innovation with expertise.

Meet the seasoned experts providing counsel on our approach to AI and pharma R&D.

Our scientific advisory board.

We stand on the shoulders of giants in AI and pharma R&D.

Their collective wisdom and expertise serve as a compass for our endeavors, ensuring that our innovations in AI and pharma R&D are both groundbreaking and ethically sound.

Abzu breakthroughs in discovery and AI

Abzu's scientific advisory board.

Meet the advisory team:

Former CEO of Abzu, serial entrepreneur of companies working with tech, science, and high performance computing, and inventor of Abzu’s QLattice®, a symbolic AI algorithm.

Head of the Danish Pioneer Centre for AI, professor of Computer Science at the University of Copenhagen, former Associate Dean at Cornell Tech, and visiting faculty member at Google.

Former Managing Partner at Lundbeckfonden Ventures. Board member of Dysis Medical, Cydan Development, Lexeo, Psioxus, and scPharmaceuticals. Co-founder and previous CEO of 7TM Pharma A/S.

Abzu Scientific Advisory Board member: Anders Gersel Pedersen

Anders Gersel Pedersen

Former Executive Vice President of Research + Development at Lundbeck. Deputy Chair of Bavarian Nordic and board member of Genmab, Hansa Medical, and Avillion.

Former president and CEO at Scandion Oncology, President of Genevant Sciences, and Global Head of RNA Therapeutics at Roche Innovation Center Copenhagen.

Subscribe for
notifications from Abzu.

You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.